Skip Navigation

News

  • Print
  • Comment
  • | Share

Venezuela, Uruguay sign US$427 million agreements

Daniela Hirschfeld

11 September 2007 | EN | ES

Reinaldo Gargano, ministro de Relaciones Exteriores

Reinaldo Gargano, Uruguayan minister of Foreign Affairs

Reinaldo Gargano, Uruguayan minister of Foreign Affairs

[MONTEVIDEO] Venezuela and Uruguay have signed agreements worth US$427 million to fund projects in medicine, biotechnology and cattle genetics.

The projects were announced by Uruguayan minister of foreign affairs Reinaldo Gargano last week (3 September) following a meeting of the Joint Commission Uruguay-Venezuela, which met by the end of August in Caracas, Venezuela. The meeting involved national authorities and entrepreneurs from both countries.

Uruguay will provide the knowledge and technology for the projects, which will be funded with Venezuelan money.

Uruguay has been granted US$144 million to build a pilot plant for research into the production of insulin and other biotechnology drugs. The plant will be built in facilities of the Pasteur Institute in Montevideo, Uruguay. 

Gargano said currently there are only three companies producing insulin worldwide and added that the plant could halve the cost of injectable insulin from the current US$12 per dose from 2008.

Gargano also announced the creation of a Centre for Reproductive Biotechnology and Cattle Genetics in Uruguay, with a US$70 million investment to optimise milk and meat production.

Add your comment

This is your network: share your views on any of our articles by adding your comments.

You need to be signed in to post a comment or to email a consenting comment author. Please sign in or sign up.

All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.

All SciDev.Net material is free to reproduce providing that the source and author are appropriately credited. For further details see Creative Commons.

Back to News
To the top